Rheumatic heart disease remains a major public health problem in many parts of the world. Rheumatic heart disease (RHD), the only long-term consequence of acute rheumatic fever (ARF), continues unabated among middle-income and low-income countries and in some indigenous communities of the industrialized world. At least 15 million people are estimated to be affected by RHD worldwide. Globally, india contributes nearly 25-50% of newly diagnosed cases, dealths, hospitalization and burden of RHD. The American Heart Association (AHA) has well-established clinical diagnostic criteria for ARF—the Jones criteriaand, with some modifications and revisions, these guidelines have been accepted and utilized worldwide. The standardized criteria aim to permit rapid and consistent identification of individuals with ARF and RHD hence allow enrolment into secondary prophylaxis programs. However, important unanswered questions remain about the importance of subclinical disease (RHD on echocardiography without a clinical pathological murmur), and about the practicalities of implementing screening programs. These standardized criteria will help enable new studies to be designed to evaluate the role of echocardiographic screening in RHD control.
Cite this article:
Manpreet Saggi, Raman Kalia. Rheumatic Fever and Rheumatic Heart Disease. Asian J. Nursing Education and Research. 2020; 10(3): 360-364. doi: 10.5958/2349-2996.2020.00076.2
1. Negi P, Sondhi S, Asotra S et al. Current Status of Rheumatic Heart Disease in India. Indian Journal2019. (Available online)
2. Watkins DA, Johnson CO, Colquhoun SM, Karthikeyan G, Beaton A, Bukhman G, et al. Global, regional, and national burden of rheumatic heart disease, 1990-2015. The New England Journal of Medicine2017; 377:713-22.
3. Basu UP. Preliminary observations on acquired diseases of the heart and aorta as met with in Bengal. Indian Med Gaz. 60:307–10.
4. Guidelines for the diagnosis of rheumatic fever. Jone criteria. 1992 update. Special Writing Group of the Committee on Rheumatic fever, Endocarditis and Kawasaki disease of the Council on Cardiovascular Disease in the young of the American Heart Association. JAMA. 1992; 268:2069–73.
5. Kumar R. Rheumatic Heart disease: a neglected public health priority. Indian Journal of Public health. 2019: 63(1); 1-3.
6. Tandon R. Rheumatic fever pathogenesis: Approach in research needs change. Annals of Pediatric Cardiology. 2012; 5:169–78.
7. Kumar R K, Tondon R. Rheumatic disease and Rheumatic heart disease: the last 50 years. IJMR. 2013 Apr; 137(4): 643–658.
8. Dajani A, Taubert K, Ferrieri P, Peter U, Shulman S. Treatment of acute streptococcal pharyngitis and prevention of rheumative fever: a statement for health professionals. Committee on Rheumatic fever, Endocarditis and Kawasaki Disease of the Council on Cardiovascular disease in the young, the American Heart Association. Pediatrics. 1995; 96:758–64.